Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Theratechnologies Inc. logo — Health innovation that matters | #HIV #NASH #Oncology

Theratechnologies Inc.

Health innovation that matters | #HIV #NASH #Oncology

Founded 1993 Canada Montreal, Canada 98 employees Post Ipo Equity Total: $216.26M Biotechnology, Pharmaceutical

General Information

Company Name Theratechnologies Inc.
Founded Year 1993
Location Canada Montreal, Canada +2
Employees 98
Industries Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Theratechnologies Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Theratechnologies Inc.

Theratechnologies Inc. is a Canadian clinical-stage biopharmaceutical company founded in 1993, focusing on the development and commercialization of innovative therapies. The company's slogan, "Health innovation that matters | #HIV #NASH #Oncology," reflects its dedicated focus on addressing critical health issues. Currently, Theratechnologies markets prescription products for individuals with HIV in the United States, and their research pipeline is directed towards developing specialized therapies to meet unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH), and oncology. The company recently secured a $12.50M post-IPO equity investment on 26 October 2023, reflecting strong investor confidence in Theratechnologies' potential and the value of its innovative therapies. This investment will likely further bolster the company's efforts to advance its pipeline and bring new treatments to market. With a focus on the biotechnology and pharmaceutical industries, Theratechnologies is well-positioned to leverage its expertise and drive advancements in the therapeutic landscape, making a meaningful impact on patient care and outcomes.

Taxonomy: Theratechnologies, clinical-stage biopharmaceutical, prescription products, HIV, NASH, oncology, innovative therapies, research pipeline, unmet medical needs, commercialization, health innovation, biopharmaceutical company, specialized therapies, medical research, scientific breakthroughs

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 26 Oct 2023
Post-IPO Debt •••••• 1
Investor
27 Jul 2022
Post-IPO Equity •••••• - 19 Jan 2021
Post-IPO Debt •••••• - 19 Jun 2018
Post-IPO Equity •••••• - 14 Nov 2016

View All 6 Funding Rounds

Theratechnologies Inc. Alternatives & Competitors

Theratechnologies Inc. vs
Alladapt Immunotherapeutics, Inc.
Alladapt Immunotherapeutics, Inc. United States

A biopharmaceutical company developing prescription therapies for unmet needs in the field of Food A...

Debt Financing
7 employees
Biotechnology
Compare Theratechnologies Inc. vs Alladapt Immunotherapeutics, Inc.
Theratechnologies Inc. vs
Odyssey Thera
Odyssey Thera

Pioneering cellular pharmacology to discover groundbreaking cancer therapies.

Series Unknown
11-50 employees
Biopharma, Biotechnology
Compare Theratechnologies Inc. vs Odyssey Thera
Theratechnologies Inc. vs
Nitrase Therapeutics
Nitrase Therapeutics United States

Pioneering Nitrase Biology and Medicines

Series A
13 employees
Biotechnology, Health Care
Compare Theratechnologies Inc. vs Nitrase Therapeutics

FAQ About Theratechnologies Inc.

Health innovation that matters | #HIV #NASH #Oncology
Theratechnologies Inc. was founded in 1993.
Theratechnologies Inc. is headquartered in Montreal, Canada.
Theratechnologies Inc. operates in the following industries: Biotechnology, Pharmaceutical.
Theratechnologies Inc. has approximately 98 employees.
Theratechnologies Inc. has completed 6 funding rounds, raising a total of $216.26M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Theratechnologies Inc. include Alladapt Immunotherapeutics, Inc., Odyssey Thera, Nitrase Therapeutics, Anchiano Therapeutics, Dermavant Sciences, an Organon company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Theratechnologies Inc. and Alladapt Immunotherapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Theratechnologies Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy